SEC Filing Summary: Landec Corporation (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Landec Corporation (not Lifecore Biomedical, Inc.) on October 1, 2019. The report serves to announce the consolidated financial results for the first quarter of fiscal year 2020. The specific financial data is contained within a press release furnished as Exhibit 99.1, which is not included in the provided text.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1), the content of which is not present in the source material.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms that results for the first quarter of fiscal year 2020 were announced.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risks, contingencies, or unusual items. The filing explicitly states that the information in the press release is furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, nor incorporated by reference unless expressly stated.
Investor Verification Checklist
- Verify the actual financial figures (revenue, net income, EPS) by reviewing the full text of the press release (Exhibit 99.1) referenced in this filing.
- Confirm the discrepancy between the requested company name (Lifecore Biomedical, Inc.) and the actual registrant (Landec Corporation).
- Review the full press release for any guidance or outlook statements not captured in this summary.
- Check subsequent filings for any updates or corrections to the Q1 FY2020 results.